When to Blind Your Teaser
By Brendan Balthis, M&A Advisor, Tuck Advisors
Do we blind the teaser, or do we put our name on it?
At Tuck Advisors, we generally prefer going to market unblinded. Showing your company name filters the field early, attracts serious buyers, and helps you avoid tire-kickers who are curious but not credible. Blinding the teaser can suppress response rates and make strategic buyers reluctant to engage. But failing to blind when the situation calls for it can genuinely disrupt the business you're trying to sell. There are four situations that call for a blinded teaser.
When Customer Relationships Are Fragile or Concentrated
Early disclosure creates risk when a significant share of revenue comes from a few key accounts. Customers may worry about contract stability or service quality and start looking for alternatives before you've even chosen a buyer. Blinding the teaser buys time to find the right partner before your most important accounts have a reason to reconsider.
When Your Team Doesn't Know Yet
Key departures during a sale process hurt operations, but they also signal instability to buyers. An intact, motivated management team is a value driver. A company losing people during diligence is a red flag, one that often invites retrading. If your leadership team isn't in the loop yet, a named teaser circulating to tens or hundreds of buyers before NDAs are signed genuinely risks leaks. Blinding the teaser keeps the information contained until the right time.
When Competitors Could Exploit the Window
A sales process is inherently distracting. You're managing diligence, answering buyer questions, and negotiating, all while simultaneously trying to run the business. In competitive markets, that distraction is a vulnerability.
Competitors who learn that you are in transition may accelerate a product launch, target your accounts, or recruit your staff while your attention is elsewhere. In some industries, this risk is minimal. In others—particularly where the buyers and the competitive landscape substantially overlap—it's very real. If there's a meaningful risk that your teaser may reach a competitor before it reaches a serious buyer, blinding is the right decision.
When a Key Partner, Supplier, or Distributor Could Destabilize the Deal
This is the scenario that surprises sellers most. Partners and suppliers are often seen as allies, and in most cases they are. But a potential sale creates uncertainty that even well-meaning partners may struggle to learn about discreetly.
A key supplier might tighten payment terms after sensing a change in ownership, a distribution partner might start hedging by building relationships with your competitors, a licensor might question whether their agreement survives a change of control. None of this has to be adversarial in order to be damaging. They don't have to intend harm to cause it. It's merely self-preservation, and it causes friction at exactly the wrong moment.
A well-run process maps and manages change-of-control provisions proactively. That work is far easier when news of a sale isn't already circulating. If a partner or supplier relationship is close enough that early word of a transaction could prompt moves that jeopardize the deal, blinding lets you control the timeline.
A Note on Unblinding
But blinding a teaser doesn't mean you stay blind indefinitely. Once a buyer signs an NDA, they get the full picture: your name, team, financials, customer relationships, and more. That is the right time for that information to be shared: when it is legally protected, and when the buyer has cleared at least a preliminary screen for fit and intent.
The blind teaser is a filter, not a wall. The decision is always situational, and it is one we make deliberately.
The Bottom Line
The teaser is the first document your business sends into the market. Getting the decision right is part of the value of a good advisor. If any of the four situations above describe your business, it's worth having that conversation before a single document is signed.
Brendan Balthis is an M&A Advisor at Tuck Advisors, specializing in sell-side transactions in Education and Healthcare.
